These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 776529)

  • 41. International Conference on Harmonisation; choice of control group and related issues in clinical trials; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 May; 66(93):24390-1. PubMed ID: 12356096
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Haloperidol: a quarter century of experience.
    Settle EC; Ayd FJ
    J Clin Psychiatry; 1983 Dec; 44(12):440-8. PubMed ID: 6418723
    [TBL] [Abstract][Full Text] [Related]  

  • 43. United States Food and Drug Administration requirements for approval of generic drug products.
    Meyer MC
    J Clin Psychiatry; 2001; 62 Suppl 5():4-9; discussion 23-4. PubMed ID: 11305846
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Generic equivalents: issues and concerns.
    Lamy PP
    J Clin Pharmacol; 1986; 26(5):309-16. PubMed ID: 3700686
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of 75/75 rule: FDA viewpoint.
    Cabana BE
    J Pharm Sci; 1983 Jan; 72(1):98-100. PubMed ID: 6827472
    [No Abstract]   [Full Text] [Related]  

  • 46. Generics in benzodiazepine therapy.
    Mann RJ
    Hosp Pract (Off Ed); 1990 Sep; 25 Suppl 3():24-31; discussion 32-4. PubMed ID: 1976122
    [No Abstract]   [Full Text] [Related]  

  • 47. Controversies in bioequivalence studies.
    Steinijans VW; Hauschke D; Jonkman JH
    Clin Pharmacokinet; 1992 Apr; 22(4):247-53. PubMed ID: 1606785
    [No Abstract]   [Full Text] [Related]  

  • 48. Issues in clinical trial design from the FDA perspective.
    Katz R
    Epilepsia; 2003; 44 Suppl 7():9-15. PubMed ID: 12919333
    [No Abstract]   [Full Text] [Related]  

  • 49. CER in 2010.
    Printz C
    Cancer; 2010 Mar; 116(5):1147-9. PubMed ID: 20169592
    [No Abstract]   [Full Text] [Related]  

  • 50. Need for U-40 insulin.
    Rabin J
    JAMA; 1979 Mar; 241(12):1230. PubMed ID: 153979
    [No Abstract]   [Full Text] [Related]  

  • 51. Extemporaneous vs commercial formulations of steroids for topical usage.
    Burdick KH
    JAMA; 1970 May; 212(8):1380. PubMed ID: 5467538
    [No Abstract]   [Full Text] [Related]  

  • 52. A teaspoonful of medicine, a teaspoonful of trouble?
    J Pract Nurs; 1979 Jul; 29(7):36. PubMed ID: 255613
    [No Abstract]   [Full Text] [Related]  

  • 53. Establishing therapeutic equivalency. What is a clinically significant difference?
    Detsky AS; Sackett DL
    Arch Intern Med; 1986 May; 146(5):861-2. PubMed ID: 3963974
    [No Abstract]   [Full Text] [Related]  

  • 54. When do differences in dissolution profiles predict clinical problems?
    Ngo SN
    J Clin Pharm Ther; 2007 Apr; 32(2):111-2. PubMed ID: 17381660
    [No Abstract]   [Full Text] [Related]  

  • 55. Some effects of drug laws and regulations on the practice of medicine, with particular emphasis on inflammatory bowel disease.
    Goldstein F
    Am J Gastroenterol; 1988 Oct; 83(10):1091-7. PubMed ID: 3421219
    [No Abstract]   [Full Text] [Related]  

  • 56. Bioavailability and bioequivalence trials: statistics & pharmacokinetic principles.
    Rajaram L; Roy SK; Skerjanec A
    Stud Health Technol Inform; 2004; 103():159-79. PubMed ID: 15747918
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dosage form performance: a major factor in clinical medicine.
    Dittert LW
    Conn Med; 1976 May; 40(5):333-7. PubMed ID: 776529
    [No Abstract]   [Full Text] [Related]  

  • 58. Aspects of bioavailability and bioequivalence revision: possible implications on clinical pharmacology.
    Glasser AC
    Methods Find Exp Clin Pharmacol; 1987 Jul; 9(7):449-52. PubMed ID: 3683019
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.